|Ticker||Status||Jurisdiction||Filing Date||CP Start||CP End||CP Loss||Deadline|
|Ticker||Case Name||Status||CP Start||CP End||Deadline||Settlement Amt|
|Ticker||Name||Date||Analyst Firm||Up/Down||Target ($)||Rating Change||Rating Current|
Major Wall Street indices closed mixed on Tuesday as a disparate set of corporate earnings dampened the existing euphoria over the possibility of a slowdown in rate hikes. Although the Dow Jones closed 0.31% higher, the Nasdaq Composite ended the session 0.27% lower and the S&P 500, too, closed marginally in the red. Meanwhile, the following five stocks are drawing investors’ attention:
1. Tesla Inc (NASDAQ:TSLA): Shares of Tesla ended marginally in the green on Tuesday. The company said it would invest over $3.6 billion to grow its Nevada manufacturing complex with two new factories, reported Reuters. Meanwhile, Chief Executive Elon Musk testified on Tuesday, saying although he anticipated strong financial support when he tweeted he would take Tesla private in 2018, he admitted that he did not have specific commitments from prospective backers. The company is set to give its latest quarterly earnings report on Wednesday.
2. Amazon.com, Inc. (NASDAQ:AMZN): Shares of Amazon closed 1.23% lower on Tuesday while they lost another 1.32% in extended trading. The company announced RxPass, a new Prime membership benefit from Amazon Pharmacy that offers patients affordable access to commonly prescribed generic medications that treat over 80 common health conditions, according to a release.
3. Microsoft Corp (NASDAQ:MSFT): Microsoft shares ended 0.22% lower on Tuesday and lost 0.95% in extended trading as it announced its quarterly earnings. Microsoft reported second-quarter revenue of $52.7 billion, missing a Street estimate of $52.97 billion. Earnings per share stood at $2.32 in the second quarter, beating a Street estimate of $2.30.
4. Cassava Sciences Inc (NASDAQ:SAVA): Shares of Cassava closed 19.21% lower on Tuesday. Although the company reported positive top-line Phase 2 results for simufilam, its oral drug candidate for Alzheimer’s disease and dementia, investors seem to have been disappointed.
5. Intuitive Surgical, Inc. (NASDAQ:ISRG): Shares of the company lost 10.08% in extended trading on Tuesday after the company announced fourth-quarter results that disappointed the Street. The company’s fourth-quarter revenue increased 7% year-over-year to $1.66 billion, which missed average estimates of $1.67 billion. Its earnings per share of $1.23 too missed estimates of $1.25 per share.